Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1996
Mucosal addressin cell adhesion molecule-1: a structural and functional analysis demarcates the integrin binding motifJ L Viney, S Jones, H H Chiu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2007
BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammationHeather A Arnett, Sabine S Escobar, Eva Gonzalez-Suarez, et al.
Nature|June 23, 1994
Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in alpha beta(+) T cellsL Wen, S J Roberts, J L Viney, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 30, 2013
Butyrophilin-like 2 modulates B7 costimulation to induce Foxp3 expression and regulatory T cell development in mature T cellsRyan M Swanson, Marc A Gavin, Sabine S Escobar, et al.
EMBO Molecular Medicine|March 13, 2015
Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanismsAlex Pellerin, Karel Otero, Julie M Czerkowicz, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2015
Discovery of biaryl carboxylamides as potent RORγ inverse agonistsJianhua Chao, Istvan Enyedy, Kurt Van Vloten, et al.
The Journal of Experimental Medicine|March 8, 2000
Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient miceM K Kennedy, M Glaccum, S N Brown, et al.
Scientific Reports|March 16, 2019
Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patientsLoubna Chadli, Britt Sotthewes, Kejie Li, et al.
Plos One|October 21, 2016
Pristane-Accelerated Autoimmune Disease in (SWR X NZB) F1 Mice Leads to Prominent Tubulointerstitial Inflammation and Human Lupus Nephritis-Like FibrosisAgnes Gardet, Wei C Chou, Taylor L Reynolds, et al.
Immunohorizons|March 26, 2025
Safety, pharmacokinetics, and pharmacodynamics of MK-6194, an IL-2 mutein designed to selectively activate regulatory T cells: single ascending dose and multiple ascending dose trial dataJohannes F Scheid, Kiki Cunningham-Bussel, Nancy Kim, et al.
Pageof 9